Limbach (NASDAQ:LMB – Get Free Report) released its quarterly earnings data on Monday. The construction company reported $1.15 EPS for the quarter, topping the consensus estimate of $0.84 by $0.31, Zacks reports. Limbach had a return on equity of 20.16% and a net margin of 5.08%.
Limbach Trading Down 5.2 %
NASDAQ:LMB traded down $3.77 during mid-day trading on Monday, hitting $68.92. 242,635 shares of the stock traded hands, compared to its average volume of 188,015. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $776.94 million, a price-to-earnings ratio of 31.33, a PEG ratio of 2.22 and a beta of 1.18. Limbach has a 52 week low of $38.03 and a 52 week high of $107.00. The firm’s 50 day moving average is $90.72 and its two-hundred day moving average is $85.38.
Insider Activity
In related news, Director David Richard Gaboury bought 531 shares of the stock in a transaction dated Tuesday, December 10th. The stock was purchased at an average cost of $94.51 per share, with a total value of $50,184.81. Following the completion of the purchase, the director now owns 2,071 shares of the company’s stock, valued at $195,730.21. This trade represents a 34.48 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 10.20% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Stock Report on LMB
Limbach Company Profile
Limbach Holdings, Inc operates as a building systems solution company in the United States. It operates through two segments, General Contractor Relationships and Owner Direct Relationships. The company engages in the construction and renovation projects that involve primarily include mechanical, plumbing, and electrical services.
See Also
- Five stocks we like better than Limbach
- Transportation Stocks Investing
- How to Protect Your Portfolio When Inflation Is Rising
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Limbach Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limbach and related companies with MarketBeat.com's FREE daily email newsletter.